Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot crossover study of stopwatch-assessed onset of soothing and cooling effects of Gaviscon liquids after a refluxogenic meal
2007-005821-31Phase 4Completed
- Sponsor
- Reckitt
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of Gaviscon Double Action and gaviscon advance in gastroesophageal reflux disease (GERD) (4 arms), sponsored by Reckitt. Primary endpoint: Time to first perceived soothing effect. Started Nov 2007; status: completed.
02
Drugs
Gaviscon Double Actiongaviscon advance
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2007-005821-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005821-31.